Related Experiment Video
Updated: Aug 21, 2026

Real-World M3-BREATHE: Toward Multimodal Mobile Monitoring of Behaviour, Respiration, and Exposures for Treatment and Health Evaluation
Published on: June 5, 2026
Wearable Personal PM 2.5 Monitoring During Wildfire Smoke Episodes in Metro Detroit
None:
Wildfire smoke has increasingly affected air quality across North America, raising concerns about the health effects of fine particulate matter (PM 2.5 ) exposure, including potential impacts on brain health. However, relatively few studies have characterized personal PM 2.5 exposure during these events using wearable monitoring. We examined daily personal PM 2.5 concentrations during wildfire smoke episodes in southeast Michigan alongside neighborhood outdoor PM 2.5 estimates. Four participants (one adolescent and three adults) wore AirBeam3 personal monitors during ongoing studies. Neighborhood outdoor PM 2.5 was estimated using the average of three nearest PurpleAir outdoor air quality sensors, and wildfire smoke days were identified using state air quality advisories. Group-level descriptive statistics summarized personal and neighborhood outdoor PM 2.5 and self-reported time spent outdoors. Exploratory within-participant analyses quantified associations between neighborhood outdoor and personal PM 2.5 concentrations on smoke and non-smoke days. Neighborhood outdoor daily PM 2.5 concentrations were higher during wildfire smoke days than non-smoke days (87.6 ± 80.2 vs. 12.3 ± 7.0 µg/m 3 ). Personal PM 2.5 concentrations were more than five times higher during wildfire smoke days (28.2 ± 20.0 vs. 5.1 ± 4.7 µg/m 3 ) than non-smoke days. Within participants, every 10 µg/m 3 increase in neighborhood PM 2.5 was associated with 2.3 µg/m 3 increase in personal PM 2.5 concentrations. Wearable PM 2.5 monitoring captured elevated personal exposures while providing individual-level exposure information beyond neighborhood outdoor air quality estimates. These findings demonstrate that wearable monitoring complements neighborhood air quality measurements by capturing individual-level exposure, providing a more comprehensive assessment of real-world wildfire smoke exposure for future studies examining the effects on brain health.
Societal Significance Statement:
Wildfire smoke is becoming more frequent and severe, exposing millions of people to unhealthy levels of fine particulate matter (PM 2.5 ). Most public air quality information comes from outdoor monitoring stations, but these measurements do not necessarily reflect the amount of pollution an individual breathes. In this study, personal PM 2.5 concentrations were generally lower than neighborhood outdoor air quality estimates, yet they increased more than fivefold during wildfire smoke events, even though participants reported spending relatively little time outdoors. Overall, more than 25% of participant-days exceeded the United States Environmental Protection Agency (EPA) 24-hour PM 2.5 standard. These findings suggest that reducing time outdoors may lessen, but not completely eliminate, wildfire smoke exposure. As evidence continues to emerge linking wildfire smoke exposure to respiratory, cardiovascular, and brain health, combining wearable personal air pollution monitors with neighborhood air quality measurements may help researchers and public health officials better understand individual exposure, support the evaluation of protective strategies such as indoor air filtration and cleaner-air spaces, and inform recommendations that better protect communities during future wildfire smoke events.
More Related Videos
10:37Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
Related Concept Videos
Inhaled Medications
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema